Advertisement
Screener

eFFECTOR Therapeutics, Inc. Interest Expense

eFFECTOR Therapeutics, Inc. Interest Expense

eFFECTOR Therapeutics, Inc. reported Interest Expense of $749.00 thousand for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.

Discontinued › Expense Statement › Interest Expense

us-gaap:InterestExpense · last filed 2024-05-09

  • eFFECTOR Therapeutics, Inc. interest expense for the quarter ending 2024-03-31 was $749.00K, a 8.71% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. interest expense for the quarter ending 2023-12-31 was $758.00K, a 8.75% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. interest expense for the quarter ending 2023-09-30 was $750.00K, a 31.58% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. interest expense for the quarter ending 2023-06-30 was $722.00K, a 42.97% increase year-over-year.
  • eFFECTOR Therapeutics, Inc. interest expense for fiscal 2023 was $2.92M, a 29.68% increase from fiscal 2022.
  • eFFECTOR Therapeutics, Inc. interest expense for fiscal 2022 was $2.25M, a 27.61% increase from fiscal 2021.
  • eFFECTOR Therapeutics, Inc. interest expense for fiscal 2021 was $1.76M, a 32.33% increase from fiscal 2020.
  • eFFECTOR Therapeutics, Inc. interest expense for fiscal 2020 was $1.33M.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2024-03-31$749.00K
10-Q · filed 2024-05-09
$1.51M
derived: sum of 2 quarters · filed 2024-05-09
$2.26M
derived: sum of 3 quarters · filed 2024-05-09
$2.98M
derived: sum of 4 quarters · filed 2024-05-09
2023-12-31$758.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$1.51M
derived: sum of 2 quarters · filed 2024-03-26
$2.23M
derived: sum of 3 quarters · filed 2024-03-26
$2.92M
10-K · filed 2024-03-26
2023-09-30$750.00K
10-Q · filed 2023-11-13
$1.47M
derived: sum of 2 quarters · filed 2023-11-13
$2.16M
10-Q · filed 2023-11-13
$2.86M
derived: sum of 4 quarters · filed 2024-05-09
2023-06-30$722.00K
10-Q · filed 2023-08-08
$1.41M
10-Q · filed 2023-08-08
$2.11M
derived: sum of 3 quarters · filed 2024-05-09
$2.68M
derived: sum of 4 quarters · filed 2024-05-09
2023-03-31$689.00K
10-Q · filed 2024-05-09
$1.39M
derived: sum of 2 quarters · filed 2024-05-09
$1.96M
derived: sum of 3 quarters · filed 2024-05-09
$2.46M
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31$697.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26
$1.27M
derived: sum of 2 quarters · filed 2024-03-26
$1.77M
derived: sum of 3 quarters · filed 2024-03-26
$2.25M
10-K · filed 2024-03-26
2022-09-30$570.00K
10-Q · filed 2023-11-13
$1.07M
derived: sum of 2 quarters · filed 2023-11-13
$1.55M
10-Q · filed 2023-11-13
$2.04M
derived: sum of 4 quarters · filed 2023-11-13
2022-06-30$505.00K
10-Q · filed 2023-08-08
$983.00K
10-Q · filed 2023-08-08
$1.47M
derived: sum of 3 quarters · filed 2023-08-08
$1.96M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$478.00K
10-Q · filed 2023-05-09
$968.00K
derived: sum of 2 quarters · filed 2023-05-09
$1.46M
derived: sum of 3 quarters · filed 2023-05-09
$1.94M
derived: sum of 4 quarters · filed 2023-05-09
2021-12-31$490.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08
$978.00K
derived: sum of 2 quarters · filed 2023-03-08
$1.46M
derived: sum of 3 quarters · filed 2023-03-08
$1.76M
10-K · filed 2023-03-08
2021-09-30$488.00K
10-Q · filed 2022-11-07
$968.00K
derived: sum of 2 quarters · filed 2022-11-07
$1.27M
10-Q · filed 2022-11-07
$1.59M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30$480.00K
10-Q · filed 2022-08-09
$786.00K
10-Q · filed 2022-08-09
$1.10M
derived: sum of 3 quarters · filed 2022-08-09
$1.44M
derived: sum of 4 quarters · filed 2022-08-09
2021-03-31$306.00K
10-Q · filed 2022-05-10
$620.00K
derived: sum of 2 quarters · filed 2022-05-10
$962.00K
derived: sum of 3 quarters · filed 2022-05-10
$1.30M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$314.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16
$656.00K
derived: sum of 2 quarters · filed 2022-03-16
$996.00K
derived: sum of 3 quarters · filed 2022-03-16
$1.33M
10-K · filed 2022-03-16
2020-09-30$342.00K
10-Q · filed 2021-11-08
$682.00K
derived: sum of 2 quarters · filed 2021-11-08
$1.02M
10-Q · filed 2021-11-08
2020-06-30$340.00K
8-K · filed 2021-08-31
$678.00K
8-K · filed 2021-08-31